# Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

> **NCT01005758** · PHASE2 · UNKNOWN · sponsor: **Ohio State University Comprehensive Cancer Center** · enrollment: 180 (estimated)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** cyclophosphamide
- **DRUG:** cytarabine
- **DRUG:** dexamethasone
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide phosphate
- **DRUG:** hydrocortisone sodium succinate
- **DRUG:** imatinib mesylate
- **DRUG:** mercaptopurine
- **DRUG:** methotrexate
- **DRUG:** methylprednisolone
- **DRUG:** pegaspargase
- **DRUG:** prednisolone
- **DRUG:** prednisone
- **DRUG:** vincristine sulfate
- **OTHER:** laboratory biomarker analysis
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT01005758
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2013-01
- **Final completion:** —
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2014-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01005758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01005758, "Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01005758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*